Sarolaner
Prevention and treatment of flea, tick and other ectoparasite infestations in dogs and cats
- CAS No.
- 1398609-39-6
- Indication Class
- Animal Health
- Patent Expiry
- To be assessed
- Therapeutic Area
- Animal Health
- Labeled Purity
- 98%+
- Registration Readiness
- GMP/DMF
- Commercialization Tier
- API (Commercialized)
- Linked Intermediates
- 2 key intermediates available
Key Intermediates for This API
Order: listed intermediates that accept enquiries first; fragments shared across several APIs rank higher| Intermediate | CAS | Shared | Action |
|---|---|---|---|
| 1-(3,5-Dichloro-4-fluorophenyl)-2,2,2-trifluoroethanone | 1190865-44-1 | — | |
| tert-Butyl 5'-acetyl-3'H-spiro[azetidine-3,1'-isobenzofuran]-1-carboxylate | 1398609-81-8 | — |
Listing Logic · Why It's Worth Listing
One of several same-class agents, suitable as a combination supply within an animal-health portfolio to meet customers' generic and differentiated sourcing needs.
Animal Health · Marketed; available for immediate sourcing
GMP/DMF-ready; supports regulatory filing and audit in target markets
2 key intermediates available; scale-up and cost control manageable
Product Description
Sarolaner is an oral, prescription parasiticide for dogs, belonging to the isoxazoline class, used to kill and control fleas and ticks by disrupting their central nervous system after a blood meal, offering monthly protection and also used off-label for mites like Sarcoptes and Demodex.
Supply source: Unibest · Sarolaner, sourced, vetted and delivered by Unibest. Therapeutic area, indication and listing rationale are qualitative summaries based on public drug knowledge for business reference; actual registration availability and quality specifications are subject to DMF/GMP documentation and the technical agreement confirmed at order.